ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,480 | -79.9% | 10,912 | -72.4% | 0.00% | – |
| Q2 2023 | $141,500 | +58.7% | 39,525 | -3.4% | 0.00% | – |
| Q1 2023 | $89,173 | -94.4% | 40,905 | -69.2% | 0.00% | -100.0% |
| Q4 2022 | $1,599,906 | +488.2% | 132,993 | +216.8% | 0.00% | – |
| Q3 2022 | $272,000 | -19.0% | 41,985 | -42.8% | 0.00% | – |
| Q2 2022 | $336,000 | -53.8% | 73,414 | -12.7% | 0.00% | – |
| Q1 2022 | $728,000 | -71.2% | 84,119 | -52.4% | 0.00% | – |
| Q4 2021 | $2,525,000 | -46.3% | 176,740 | -17.4% | 0.00% | -100.0% |
| Q3 2021 | $4,702,000 | +713.5% | 213,910 | +395.0% | 0.00% | – |
| Q2 2021 | $578,000 | +572.1% | 43,211 | +113.0% | 0.00% | – |
| Q4 2020 | $86,000 | +1.2% | 20,291 | -38.0% | 0.00% | – |
| Q3 2020 | $85,000 | +16.4% | 32,735 | +59.4% | 0.00% | – |
| Q2 2020 | $73,000 | -62.8% | 20,542 | -46.0% | 0.00% | – |
| Q4 2019 | $196,000 | +164.9% | 38,067 | +64.9% | 0.00% | – |
| Q3 2019 | $74,000 | -52.3% | 23,085 | -46.6% | 0.00% | – |
| Q2 2019 | $155,000 | -11.9% | 43,212 | +189.1% | 0.00% | -100.0% |
| Q1 2014 | $176,000 | – | 14,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 781,292 | $2,039,172 | 1.87% |
| GSA CAPITAL PARTNERS LLP | 88,923 | $232 | 0.02% |
| Glass Jacobson Investment Advisors llc | 12,255 | $31,986 | 0.02% |
| Rathbones Group PLC | 289,803 | $756,386 | 0.01% |
| N.E.W. Advisory Services LLC | 12,960 | $33,826 | 0.01% |
| Virtu Financial LLC | 17,388 | $45 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $14,687 | 0.00% |
| ALGERT GLOBAL LLC | 14,680 | $38 | 0.00% |
| Close Asset Management Ltd | 11,400 | $30 | 0.00% |
| Altshuler Shaham Ltd | 12,847 | $33,408 | 0.00% |